Literature DB >> 32672118

The effect of thermal therapy on the blood-brain barrier and blood-tumor barrier.

Bhuvic Patel1, Peter H Yang1, Albert H Kim1.   

Abstract

The blood-brain and blood-tumor barriers represent highly specialized structures responsible for tight regulation of molecular transit into the central nervous system. Under normal circumstances, the relative impermeability of the blood-brain barrier (BBB) protects the brain from circulating toxins and contributes to a brain microenvironment necessary for optimal neuronal function. However, in the context of tumors and other diseases of central nervous system, the BBB and the more recently appreciated blood-tumor barrier (BTB) represent barriers that prevent effective drug delivery. Overcoming both barriers to optimize treatment of central nervous system diseases remains the subject of intense scientific investigation. Although many newer technologies have been developed to overcome these barriers, thermal therapy, which dates back to the 1890 s, has been known to disrupt the BBB since at least the early 1980s. Recently, as a result of several technological advances, laser interstitial thermal therapy (LITT), a method of delivering targeted thermal therapy, has gained widespread use as a surgical technique to ablate brain tumors. In addition, accumulating evidence indicates that laser ablation may also increase local BBB/BTB permeability after treatment. We herein review the structure and function of the BBB and BTB and the impact of thermal injury, including LITT, on barrier function.

Entities:  

Keywords:  Laser interstitial thermal therapy; blood-brain barrier; blood-tumor barrier; brain tumors; glioblastoma

Mesh:

Year:  2020        PMID: 32672118      PMCID: PMC7709344          DOI: 10.1080/02656736.2020.1783461

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  80 in total

1.  ATP mediates rapid microglial response to local brain injury in vivo.

Authors:  Dimitrios Davalos; Jaime Grutzendler; Guang Yang; Jiyun V Kim; Yi Zuo; Steffen Jung; Dan R Littman; Michael L Dustin; Wen-Biao Gan
Journal:  Nat Neurosci       Date:  2005-05-15       Impact factor: 24.884

2.  Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.

Authors:  Corrado Santarosa; Antonella Castellano; Gian Marco Conte; Marcello Cadioli; Antonella Iadanza; Maria Rosa Terreni; Alberto Franzin; Lorenzo Bello; Massimo Caulo; Andrea Falini; Nicoletta Anzalone
Journal:  Eur J Radiol       Date:  2016-03-22       Impact factor: 3.528

Review 3.  Phototherapy in tumors.

Authors:  S G Bown
Journal:  World J Surg       Date:  1983-11       Impact factor: 3.352

4.  Clinical trial of blood-brain barrier disruption by pulsed ultrasound.

Authors:  Alexandre Carpentier; Michael Canney; Alexandre Vignot; Vincent Reina; Kevin Beccaria; Catherine Horodyckid; Carine Karachi; Delphine Leclercq; Cyril Lafon; Jean-Yves Chapelon; Laurent Capelle; Philippe Cornu; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Sci Transl Med       Date:  2016-06-15       Impact factor: 17.956

Review 5.  Multidrug resistance-associated proteins: expression and function in the central nervous system.

Authors:  Shannon Dallas; David S Miller; Reina Bendayan
Journal:  Pharmacol Rev       Date:  2006-06       Impact factor: 25.468

6.  ANG4043, a novel brain-penetrant peptide-mAb conjugate, is efficacious against HER2-positive intracranial tumors in mice.

Authors:  Anthony Regina; Michel Demeule; Sasmita Tripathy; Simon Lord-Dufour; Jean-Christophe Currie; Mustapha Iddir; Borhane Annabi; Jean-Paul Castaigne; Jean E Lachowicz
Journal:  Mol Cancer Ther       Date:  2014-12-09       Impact factor: 6.261

7.  Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma.

Authors:  Philippe Menei; Eric Jadaud; Nathalie Faisant; Michèle Boisdron-Celle; Sophie Michalak; Dominique Fournier; Manuel Delhaye; Jean-Pierre Benoit
Journal:  Cancer       Date:  2004-01-15       Impact factor: 6.860

Review 8.  Angiogenesis in brain tumours.

Authors:  Rakesh K Jain; Emmanuelle di Tomaso; Dan G Duda; Jay S Loeffler; A Gregory Sorensen; Tracy T Batchelor
Journal:  Nat Rev Neurosci       Date:  2007-08       Impact factor: 34.870

9.  Therapeutic enhancement of blood-brain and blood-tumor barriers permeability by laser interstitial thermal therapy.

Authors:  Afshin Salehi; Mounica R Paturu; Bhuvic Patel; Matthew D Cain; Tatenda Mahlokozera; Alicia B Yang; Tsen-Hsuan Lin; Eric C Leuthardt; Hiroko Yano; Sheng-Kwei Song; Robyn S Klein; Robert Schmidt; Albert H Kim
Journal:  Neurooncol Adv       Date:  2020-06-30

10.  Management of Intracranial Metastatic Disease With Laser Interstitial Thermal Therapy.

Authors:  Afshin Salehi; Ashwin A Kamath; Eric C Leuthardt; Albert H Kim
Journal:  Front Oncol       Date:  2018-10-31       Impact factor: 6.244

View more
  8 in total

1.  Readmission risk of malignant brain tumor patients undergoing laser interstitial thermal therapy (LITT) and stereotactic needle biopsy (SNB): a covariate balancing weights analysis of the National Readmissions Database (NRD).

Authors:  Truong H Do; Madeleine A Howard; Elise F Palzer; Jared D Huling; Mohammed A Alvi; Samuel W Cramer; Ping Zhu; Reid A Johnson; James Jean; Jinci Lu; Alec B Jonason; Jacob Hanson; Luke Sabal; Kevin W Sun; Robert A McGovern; Clark C Chen
Journal:  J Neurooncol       Date:  2022-07-23       Impact factor: 4.506

2.  A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma.

Authors:  Omar H Butt; Alice Y Zhou; Jiayi Huang; William A Leidig; Alice E Silberstein; Milan G Chheda; Tanner M Johanns; George Ansstas; Jingxia Liu; Grayson Talcott; Ruth Nakiwala; Joshua S Shimony; Albert H Kim; Eric C Leuthardt; David D Tran; Jian L Campian
Journal:  Neurooncol Adv       Date:  2021-11-15

3.  Modulation of the blood-tumor barrier to enhance drug delivery and efficacy for brain metastases.

Authors:  Kathryn E Blethen; Tasneem A Arsiwala; Ross A Fladeland; Samuel A Sprowls; Dhruvi M Panchal; Chris E Adkins; Brooke N Kielkowski; Leland E Earp; Morgan J Glass; Trenton A Pritt; Yssabela M Cabuyao; Sonikpreet Aulakh; Paul R Lockman
Journal:  Neurooncol Adv       Date:  2021-11-27

4.  Opening the Blood Brain Barrier with an Electropermanent Magnet System.

Authors:  Sahar Jafari; Ittai S Baum; Oleg G Udalov; Yichien Lee; Olga Rodriguez; Stanley T Fricke; Maryam Jafari; Mostafa Amini; Roland Probst; Xinyao Tang; Cheng Chen; David J Ariando; Anjana Hevaganinge; Lamar O Mair; Christopher Albanese; Irving N Weinberg
Journal:  Pharmaceutics       Date:  2022-07-20       Impact factor: 6.525

5.  A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: The state-of-the-art.

Authors:  Mateusz Pinkiewicz; Milosz Pinkiewicz; Jerzy Walecki; Michał Zawadzki
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

Review 6.  Blood-Brain Barrier Modulation to Improve Glioma Drug Delivery.

Authors:  Huilong Luo; Eric V Shusta
Journal:  Pharmaceutics       Date:  2020-11-12       Impact factor: 6.321

7.  Introduction to laser thermal therapy for brain disorders.

Authors:  Jennifer S Yu; Alireza M Mohammadi
Journal:  Int J Hyperthermia       Date:  2020-07       Impact factor: 3.914

Review 8.  Modulation of the Blood-Brain Barrier for Drug Delivery to Brain.

Authors:  Liang Han
Journal:  Pharmaceutics       Date:  2021-11-27       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.